Resultados de procura - Prawira, Amy
- Mostrando 1 - 7 Resultados de 7
-
1
-
2
Giant Prolactinoma Presenting As a Base of Skull Tumor With Nasopharyngeal Extension: A Potential Diagnostic Pitfall in Neuroendocrine Lesions of the Base of Skull por Prawira, Amy, Lazinski, Dorothy, Siu, Lillian L., Perez-Ordonez, Bayardo
Publicado 2017Text -
3
Pantoprazole Affecting Docetaxel Resistance Pathways via Autophagy (PANDORA): Phase II Trial of High Dose Pantoprazole (Autophagy Inhibitor) with Docetaxel in Metastatic Castration... por Hansen, Aaron R., Tannock, Ian F., Templeton, Arnoud, Chen, Eric, Evans, Andrew, Knox, Jennifer, Prawira, Amy, Sridhar, Srikala S., Tan, Susie, Vera‐Badillo, Francisco, Wang, Lisa, Wouters, Bradly G., Joshua, Anthony M.
Publicado 2019Text -
4
Safety and antitumor activity of the anti–PD-1 antibody pembrolizumab in patients with advanced, PD-L1–positive papillary or follicular thyroid cancer por Mehnert, Janice M., Varga, Andrea, Brose, Marcia S., Aggarwal, Rahul R., Lin, Chia-Chi, Prawira, Amy, de Braud, Filippo, Tamura, Kenji, Doi, Toshihiko, Piha-Paul, Sarina A., Gilbert, Jill, Saraf, Sanatan, Thanigaimani, Pradeep, Cheng, Jonathan D., Keam, Bhumsuk
Publicado 2019Text -
5
Dual checkpoint targeting of B7-H3 and PD-1 with enoblituzumab and pembrolizumab in advanced solid tumors: interim results from a multicenter phase I/II trial por Aggarwal, Charu, Prawira, Amy, Antonia, Scott, Rahma, Osama, Tolcher, Anthony, Cohen, Roger B, Lou, Yanyan, Hauke, Ralph, Vogelzang, Nicholas, P Zandberg, Dan, Kalebasty, Arash Rezazadeh, Atkinson, Victoria, Adjei, Alex A, Seetharam, Mahesh, Birnbaum, Ariel, Weickhardt, Andrew, Ganju, Vinod, Joshua, Anthony M, Cavallo, Rosetta, Peng, Linda, Zhang, Xiaoyu, Kaul, Sanjeev, Baughman, Jan, Bonvini, Ezio, Moore, Paul A, Goldberg, Stacie M, Arnaldez, Fernanda I, Ferris, Robert L, Lakhani, Nehal J
Publicado 2022Text -
6
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study por Oliva, Marc, Chepeha, Douglas, Araujo, Daniel V, Diaz-Mejia, J. Javier, Olson, Peter, Prawira, Amy, Spreafico, Anna, Bratman, Scott V, Shek, Tina, de Almeida, John, R Hansen, Aaron, Hope, Andrew, Goldstein, David, Weinreb, Ilan, Smith, Stephen, Perez-Ordoñez, Bayardo, Irish, Jonathan, Torti, Dax, Bruce, Jeffrey P., Wang, Ben X., Fortuna, Anthony, Pugh, Trevor J., Der-Torossian, Hirak, Shazer, Ronald, Attanasio, Nickolas, Au, Qingyan, Tin, Antony, Feeney, Jordan, Sethi, Himanshu, Aleshin, Alexey, Chen, Isan, Siu, Lillian
Publicado 2021Text -
7
Phase I/II study of the LAG-3 inhibitor ieramilimab (LAG525) ± anti-PD-1 spartalizumab (PDR001) in patients with advanced malignancies por Schöffski, Patrick, Tan, Daniel S W, Martín, Miguel, Ochoa-de-Olza, María, Sarantopoulos, John, Carvajal, Richard D, Kyi, Chrisann, Esaki, Taito, Prawira, Amy, Akerley, Wallace, De Braud, Filippo, Hui, Rina, Zhang, Tian, Soo, Ross A, Maur, Michela, Weickhardt, Andrew, Krauss, Jürgen, Deschler-Baier, Barbara, Lau, Allen, Samant, Tanay S, Longmire, Tyler, Chowdhury, Niladri Roy, Sabatos-Peyton, Catherine A, Patel, Nidhi, Ramesh, Radha, Hu, Tiancen, Carion, Ana, Gusenleitner, Daniel, Yerramilli-Rao, Padmaja, Askoxylakis, Vasileios, Kwak, Eunice L, Hong, David S
Publicado 2022Text